ANOTHER BID: Royalty Pharma said Friday it has raised its offer to buy Irish drugmaker Elan Corp. PLC. It is now offering $13 in cash for each Elan share, and it will give stockholders the right to receive up to an additional $2.50 per share in milestone-based payments.
ELAN'S RESPONSE: Elan said its board will review the new offer, and its shareholders should take no action in the meantime.
THE HISTORY: Royalty first made an offer to buy Elan in February, and its latest bid before Friday totaled $12.50 per share. Elan has said that undervalued the company.
- Health Care Industry